ADMA BIOLOGICS, INC.·4

Aug 30, 4:58 PM ET

Grossman Jerrold B 4

4 · ADMA BIOLOGICS, INC. · Filed Aug 30, 2023

Insider Transaction Report

Form 4
Period: 2023-08-30
Transactions
  • Purchase

    Common Stock

    2023-08-30$3.71/sh+130,000$482,144443,265 total
Holdings
  • Common Stock

    (indirect: See Footnote)
    22,857
  • Common Stock

    (indirect: See Footnote)
    31,381
  • Common Stock

    (indirect: See Footnote)
    38,294
  • Common Stock

    (indirect: See Footnote)
    175
Footnotes (6)
  • [F1]Reflects the weighted average price of purchases on August 30, 2023. The shares were purchased in multiple transactions ranging from $3.70 to $3.71, inclusive.
  • [F2]Includes, as of the transaction date, (i) 25,815 RSUs granted on March 6, 2023 that will vest in two equal installments, on the six- and 12-month anniversaries of the grant date, becoming fully vested on the one-year anniversary of the grant date, subject to the reporting person's continued service as of the applicable vesting date; and (ii) 417,450 shares of common stock owned by the reporting person.
  • [F3]These shares are owned by Brookwood LLC ("Brookwood"). The reporting person is the managing member of Brookwood.
  • [F4]These shares are owned by the Jerrold Grossman 2019 Irrevocable Trust, of which Dr. Grossman serves as investment trustee.
  • [F5]These shares are owned by Genesis Foundation Inc. ("Genesis"). The reporting person is the President of Genesis.
  • [F6]These shares are owned by the reporting person's wife.

Documents

1 file
  • 4
    form4.xmlPrimary